Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 35 out of 100. Prevention trials

Topic: Risk, prevention and care in population studies

Introduction Multidomain programs have demonstrated efficacy in preventing cognitive decline and dementia. Additionally, technological solutions show potential for cognitive interventions and the promotion of healthy aging. This study investigated the implementation of an innovative multidomain program in a Portuguese community setting, inspired by international multidomain models and supported by technological interventions. Objectives To evaluate the effect of a multidomain program on adherence, satisfaction, and outcomes in cognitive, affective, social, and quality of life domains. Methods The program consisted of 26 sessions, held twice per week, combining robot-assisted therapy, augmented reality, computerized cognitive training, and psychoeducational sessions. Sociodemographic data and adherence records were collected, and a multidimensional assessment battery was administered before and after the intervention, along with a satisfaction questionnaire. Results The study included 504 older adults (mean age = 76 ± 9.47 years), mostly women (80.36%). Significant improvements were observed in all assessed domains (p < 0.001): cognitive (+2.6 points ACE-R), affective (–1.1 points GDS-15), social (+3.9 points ESSS), and quality of life (+1.2 points WHOQOL-BREF). Adherence was 89%, and satisfaction was 98%. Conclusions The program was effective, as evidenced by the multidimensional health gains achieved. The integration of innovative technological interventions, combined with a multidomain approach, appears promising for the prevention of cognitive decline. Future studies with control groups could strengthen the robustness and sustainability of these results. Disclosure of Interest None Declared

Key findings

Why it matters

This multidomain program in 504 older adults found improvements in cognitive, affective, social, and quality of life scores, with high adherence and satisfaction. It lacked a control group, so it cannot prove that the program prevents cognitive decline or dementia.

Study details

How this study scored 35/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 2 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record left out, no data; Institution's track record 0 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. 34 of the 96 points it could be judged on, which is 35 of 100. Total 35 of 100.34 of the 96 points we could judge = 35 of 100

Published in a peer-reviewed journal. Scored zero for study design and randomised / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 34 of the 96 points we could judge it on, which is 35 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (European Psychiatry)
Journal's citation record 1 / 4 European Psychiatry: journal h-index 143 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 2 / 4 504 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 OpenAlex's profile for last-listed author C. Pombo holds only 2 work(s), too few to judge a track record — left out of this score
Institution's track record 0 / 3 Irmãs Hospitaleiras (Portugal): institution h-index 14 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 34 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 34 of the 96 points we could judge it on is 35 out of 100.
Total 35 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Gameiro, C., Varandas, P., Lopes, B., Freitas, B., & Pombo, C. (2026). Effect of a Multicomponent Program on the Prevention of Cognitive Decline and Dementia. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2026.11579

Vancouver

Gameiro C, Varandas P, Lopes B, Freitas B, Pombo C. Effect of a Multicomponent Program on the Prevention of Cognitive Decline and Dementia. European Psychiatry. 2026. doi:10.1192/j.eurpsy.2026.11579.

BibTeX

@article{gameiro2026-9ac3fb02,
  author  = {Gameiro, C. and Varandas, P. and Lopes, B. and Freitas, B. and Pombo, C.},
  title   = {{Effect of a Multicomponent Program on the Prevention of Cognitive Decline and Dementia}},
  journal = {European Psychiatry},
  year    = {2026},
  doi     = {10.1192/j.eurpsy.2026.11579},
  url     = {https://doi.org/10.1192/j.eurpsy.2026.11579}
}

Related studies in Prevention trials

Similar studies

More on Prevention trials

See all studies in Prevention trials →